Skip to content

Clinical trials

Completed Phase 2 Opioid-Related Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Opioid-Related Disorders Phase: Phase 2 Status: Completed Clear all

135 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20024
20031
20044
20058
20064
20074
20086
20091
20104
20128
20136
20155
20171
20182
20194
20207
20214
20226
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed135

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute on Drug Abuse (NIDA)32
Yale University15
New York State Psychiatric Institute13
Johns Hopkins University11
Indivior Inc.7
University of Chicago7
University of Vermont7
University of California, Los Angeles4
Acura Pharmaceuticals Inc.3
Braeburn Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Opioid-Related Disorders135
Substance-Related Disorders28
Cocaine-Related Disorders10
Heroin Dependence9
Agnosia4
Pain4
Chronic Pain3
HIV Infections3
Alcoholism2
Parasomnias2

Trials

Showing 1 to 25 of 135. Each trial links to its page on Pharma Observatory.

35 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.